Management of<unk>  fever includes supportive care and administration of intravenous (IV) ribavirin. Data on the efficacy of antiviral agents in<unk>  fever are scarce. IV ribavirin was previously evaluated for treatment of<unk>  fever and demonstrated a reduction in mortality when administered anytime during the course of the disease, especially early within the first 6 days of symptom-onset. Ribavirin is administered intravenously for a total of 10 days using the following regimen: first, loading dose of 30 mg/kg (max. 2g) followed by a dose of 16 mg/kg (max. 1g) IV q6h for 4 days, followed by a dose of 8 mg/kg (max. 500mg) IV q8h for 6 days. In addition to antiviral therapy, management includes supportive care to adequately maintain respiratory status, as well as fluid and electrolyte balance.
Lassa fever medical therapy
Rocky Mountain spotted fever medical therapy
Marburg hemorrhagic fever medical therapy
Rift valley fever medical therapy
Paratyphoid fever medical therapy
Typhoid fever medical therapy
Tick-borne encephalitis medical therapy
Zika virus infection medical therapy